Concepedia
Publication | Open Access
Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells
28
Citations
25
References
2022
Year
Page 1